Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Short-term Clinical Pilot Trial on Safety and Immunogenicity of Nasal COVID-19 Vaccine at Different Dose Levels and Administration Methods

NCT06851611 is registered in ClinicalTrials.gov with Rokote Laboratories Finland Oy as lead sponsor.

NCT NCT06851611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06851611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Short-term Clinical Pilot Trial on Safety and Immunogenicity of Nasal COVID-19 Vaccine at Different Dose Levels and Administration Methods
Lead sponsor
Rokote Laboratories Finland Oy
Phase
Phase 1
Overall status
Completed
Start date
January 21, 2025
Completion date
June 26, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars-cov-2